Cargando…

Association between low-density lipoprotein cholesterol level and mortality in patients with cardiogenic shock: a retrospective cohort study

AIMS: Inflammation plays a key role in the pathophysiology of cardiogenic shock (CS). Low-density lipoprotein cholesterol (LDL-C) is a biomarker of inflammation and is used to predict prognostic outcomes of several diseases. The primary purpose of this study was to evaluate if LDL-C can be used as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Jiali, Shi, Zhewei, Pang, Xiaomin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256757/ https://www.ncbi.nlm.nih.gov/pubmed/34215599 http://dx.doi.org/10.1136/bmjopen-2020-044668

Ejemplares similares

Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review
por: Ravnskov, Uffe, et al.
Publicado: (2016)

Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019
por: Du, Heyue, et al.
Publicado: (2022)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis
por: Seo, Jeong Hun, et al.
Publicado: (2023)

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study
por: He, Luping, et al.
Publicado: (2023)

The CSP (Cardiogenic Shock Prognosis) Score: A Tool for Risk Stratification of Cardiogenic Shock
por: Tien, Yu-Tzu, et al.
Publicado: (2022)

Systems of Care in Cardiogenic Shock
por: Alvarez Villela, Miguel, et al.
Publicado: (2021)

Association of the Monocyte–to–High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy
por: Tang, Xixiang, et al.
Publicado: (2021)

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
por: Wu, Dongmei, et al.
Publicado: (2021)

Cardiogenic shock among cancer patients
por: Curtiaud, Anais, et al.
Publicado: (2022)

Defining levels of care in cardiogenic shock
por: Alvarez Villela, Miguel, et al.
Publicado: (2023)

Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease
por: Wang, Shih-Wei, et al.
Publicado: (2022)

Prognostic Role of Neutrophil to High-Density Lipoprotein Cholesterol Ratio for All-Cause and Cardiovascular Mortality in the General Population
por: Jiang, Ming, et al.
Publicado: (2022)

Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients
por: Yao, Younan, et al.
Publicado: (2022)

Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction
por: Chen, Min, et al.
Publicado: (2023)

The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population
por: Huang, Yu, et al.
Publicado: (2023)

Comparison of a Machine Learning Method and Various Equations for Estimating Low-Density Lipoprotein Cholesterol in Korean Populations
por: Kwon, Yu-Jin, et al.
Publicado: (2022)

U-Shaped Relationship of Low-Density Lipoprotein Cholesterol With Risk of Severe COVID-19 From a Multicenter Pooled Analysis
por: Gong, Jiao, et al.
Publicado: (2021)

Impact of Age on Outcomes in Patients With Cardiogenic Shock
por: Kanwar, Manreet, et al.
Publicado: (2021)

Editorial: Cardiogenic Shock: Basic and Clinical Considerations
por: Acharya, Deepak, et al.
Publicado: (2021)

Machine Learning for Prediction of Outcomes in Cardiogenic Shock
por: Rong, Fangning, et al.
Publicado: (2022)

The U-Shaped Association of Non-High-Density Lipoprotein Cholesterol Levels With All-Cause and Cardiovascular Mortality Among Patients With Hypertension
por: Cheng, Qi, et al.
Publicado: (2021)

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Complete Revascularisation in Impella-Supported Infarct-Related Cardiogenic Shock Patients Is Associated With Improved Mortality
por: Schäfer, Andreas, et al.
Publicado: (2021)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
por: Ward, Natalie C., et al.
Publicado: (2022)

Why Should We Measure Low-Density Lipoprotein Cholesterol Directly? Comparison of Low-Density Lipoprotein Cholesterol Assessment by Friedewald Estimation, and Direct Measurement
por: Cohen, Hofit
Publicado: (2021)

Lingua Franca of Cardiogenic Shock: Speaking the Same Language
por: Long, Ashleigh, et al.
Publicado: (2021)

Early Prediction of Cardiogenic Shock Using Machine Learning
por: Chang, Yale, et al.
Publicado: (2022)

Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial
por: Yu, Qixiang, et al.
Publicado: (2023)

Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2021)

Changes in Impaired Fasting Glucose and Borderline High Low-Density Lipoprotein-Cholesterol Status Alter the Risk of Cardiovascular Disease: A 9-Year Prospective Cohort Study
por: Wang, Xianxuan, et al.
Publicado: (2022)

In-hospital mortality of cardiogenic shock complicating ST-elevation myocardial infarction in Malaysia: a retrospective analysis of the Malaysian National Cardiovascular Database (NCVD) registry
por: Venkatason, Padmaa, et al.
Publicado: (2019)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Endothelial Lipase Is Involved in Cold-Induced High-Density Lipoprotein Turnover and Reverse Cholesterol Transport in Mice
por: Schaltenberg, Nicola, et al.
Publicado: (2021)

The interaction between uric acid and high-density lipoprotein cholesterol on the prognosis of patients with acute myocardial infarction
por: Yang, Yu, et al.
Publicado: (2023)

High-Intensity Statin vs. Low-Density Lipoprotein Cholesterol Target for Patients Undergoing Percutaneous Coronary Intervention: Insights From a Territory-Wide Cohort Study in Hong Kong
por: Ng, Andrew Kei-Yan, et al.
Publicado: (2021)

Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock
por: Ding, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ngueekhg1bg64vm1panvn52kqf